Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Barbara A. Bresnahan MD

Barbara A. Bresnahan MD


Institution: Medical College of Wisconsin
Department: Medicine
Division: Nephrology
Program: Administration


  • Lower prevalence of BK virus infection in African American renal transplant recipients: a prospective study. (Sood P, Senanayake S, Sujeet K, Medipalli R, Saad E, Vasudev B, Bresnahan BA, Johnson CP, Hariharan S) Transplantation 2012 Feb 15;93(3):291-6 PMID 22179402
  • Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report. (Vasudev M, Bresnahan BA, Cohen EP, Hari PN, Hariharan S, Vasudev BS) J Med Case Rep 2011;5:508 PMID 21982397
  • Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. (Saad ER, Bresnahan BA, Cohen EP, Lu N, Orentas RJ, Vasudev B, Hariharan S) Transplantation 2008 Mar 27;85(6):850-4 PMID 18360267
  • BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. (Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP) Kidney Int 2005 Oct;68(4):1834-9 PMID 16164661
  • Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. (Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S) Clin Transplant 2003 Oct;17(5):417-22 PMID 14703923
  • A comparison between recipients receiving matched kidney and those receiving mismatched kidney from the same cadaver donor. (Bresnahan BA, Johnson CP, McIntosh MJ, Stablein D, Hariharan S) Am J Transplant 2002 Apr;2(4):366-72 PMID 12118860
  • Post-transplant renal function in the first year predicts long-term kidney transplant survival. (Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP) Kidney Int 2002 Jul;62(1):311-8 PMID 12081593
  • Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents. (Hussain S, Bresnahan BA, Cohen EP, Hariharan S) Clin Transplant 2002 Feb;16(1):43-7 PMID 11982614
  • Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data. (Bresnahan BA, McBride MA, Cherikh WS, Hariharan S) Transplantation 2001 Jul 27;72(2):256-61 PMID 11477349
  • Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. (Ahuja M, Cohen EP, Dayer AM, Kampalath B, Chang CC, Bresnahan BA, Hariharan S) Transplantation 2001 Apr 15;71(7):896-9 PMID 11349723
  • Improved graft survival after renal transplantation in the United States, 1988 to 1996. (Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D) N Engl J Med 2000 Mar 2;342(9):605-12 PMID 10699159
  • Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury. (Lianos EA, Bresnahan BA) J Lab Clin Med 1999 Nov;134(5):478-82 PMID 10560941
  • Changes in glomerular thromboxane A2 receptor expression and ligand binding following immune injury. (Bresnahan BA, Dufek S, Wu S, Lianos EA) Kidney Int 1999 Jan;55(1):139-47 PMID 9893122
  • Cytokine inhibition preserves renal hemodynamic function following mesangial cell immune injury. (Pan CG, Bresnahan BA, Albrightson CR, Griswold D, Lianos EA) J Investig Med 1996 Aug;44(6):375-81 PMID 8795301
  • Localization of authentic thromboxane A2/prostaglandin H2 receptor in the rat kidney. (Bresnahan BA, Le Breton GC, Lianos EA) Kidney Int 1996 May;49(5):1207-13 PMID 8731083
  • Eicosanoid-induced growth and signaling events in rat glomerular mesangial cells. (Kelefiotis D, Bresnahan BA, Stratidakis I, Lianos EA) Prostaglandins 1995 May;49(5):269-83 PMID 7659782
  • Hemodynamic role of arachidonate 12- and 5-lipoxygenases in nephrotoxic serum nephritis. (Wu SH, Bresnahan BA, Lianos EA) Kidney Int 1993 Jun;43(6):1280-5 PMID 8391096
  • Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids. (Bresnahan BA, Wu S, Fenoy FJ, Roman RJ, Lianos EA) J Clin Invest 1992 Dec;90(6):2304-12 PMID 1361493
  • Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids. (Lianos EA, Bresnahan BA, Pan C) J Clin Invest 1991 Aug;88(2):623-31 PMID 1677947
  • Mesangial cell immune injury: effects of thromboxane receptor antagonism. (Bresnahan BA, Roman RJ, Bagchus WM, Lianos EA) J Am Soc Nephrol 1991 Feb;1(8):1041-7 PMID 1832980
  • Grants and Awards

  • Renal Transplantation, Homocysteine Lowering & Cognition - An Ancillary Study of the FLAVORIT Trial (#9204055 05/31/2005 - 05/31/2010) Sponsor: Tufts University
  • A Randomized, Controlled Trial of Homocysteine(FAVORIT) (#9202588 02/01/2002 - 01/31/2007) Sponsor: Rhode Island Hospital
  • Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial-EXTended Criteria Donors (BENEFIT-EXT) (#9303396 10/05/2005 - 04/29/2015) Sponsor: Bristol Myers Squibb
  • A Randomized, Controlled Trial of Homocysteine(FAVORIT) (#9204522 02/07/2007 - 06/30/2010) Sponsor: Rhode Island Hospital
  • LCP Tacro 3002 (#9305259 01/13/2011 - 01/12/2015) Sponsor: LifeCycle Pharma A/S
  • Study on Myfortic in Kidney Transplant Cerl080a2405-us01 (#9302226 04/01/2002 - 03/31/2005) Sponsor: Novartis Pharmaceuticals Corporation
  • Sudy of Prograf, Tacrolimus and Neoral in Kidney Transplant (#9302661 05/01/2003 - 09/30/2009) Sponsor: Astellas Pharma US, Inc.
  • Belatacept Evaluation of Nephroprotections and Efficacy as First-line Immunosuppression Trial (BENEFIT) (#9303513 02/15/2006 - 06/25/2015) Sponsor: Bristol Myers Squibb
  • Evaluating NULOJIX Long-Term Safety in Transplant, ENLIST Registry (#9305688 03/13/2012 - 12/30/2015) Sponsor: Parexel International, LLC
  • Last update: 03/27/2015